Show simple item record

dc.contributor.authorGilbert, A
dc.contributor.authorMcParland, L
dc.contributor.authorWebster, J
dc.contributor.authorBell, S
dc.contributor.authorCopeland, J
dc.contributor.authorAdams, RA
dc.contributor.authorHarrison, M
dc.contributor.authorMuirhead, R
dc.contributor.authorRenehan, Andrew G
dc.contributor.authorSebag-Montefiore, D
dc.contributor.authorHawkins, MA
dc.date.accessioned2019-12-09T17:23:29Z
dc.date.available2019-12-09T17:23:29Z
dc.date.issued2019en
dc.identifier.citationGilbert A, McParland L, Webster J, Bell S, Copeland J, Adams RA, et al. 535P Pre-specified pilot analysis of a randomised pilot/phase II/III trial comparing standard dose vs dose-escalated concurrent chemoradiotherapy (CRT) in anal cancer (PLATO-ACT5). Annals of Oncology. 2019;30(Supplement_5):203.en
dc.identifier.doi10.1093/annonc/mdz246.013en
dc.identifier.urihttp://hdl.handle.net/10541/622583
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz246.013en
dc.titlePre-specified pilot analysis of a randomised pilot/phase II/III trial comparing standard dose vs dose-escalated concurrent chemoradiotherapy (CRT) in anal cancer (PLATO-ACTS)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentLeeds Cancer Centre, University of Leeds, Leedsen
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2020-01-21T19:54:10Z


Files in this item

Thumbnail
Name:
mdz246.013.pdf
Size:
93.46Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract

This item appears in the following Collection(s)

Show simple item record